section name header
Index
ABO Compatibility Rule
Air Travel and Prevention of Venous Thromboembolism by Medication
Antibiotics for Acute Chest Syndrome in People with Sickle Cell Disease
Antibiotic Treatment of E. Coli O157:h7 Infections
Anticoagulants Versus Nsaids or Placebo for Venous Thromboembolism
Anticoagulation for the Long Term Treatment of Venous Thromboembolism in Patients with Cancer
Bisphosphonates and Osteonecrosis of the Jaws
Bisphosphonates in Multiple Myeloma
Blood Transfusion for Preventing Stroke in Sickle Cell Disease
Chemotherapy Plus Rituximab Versus Chemotherapy Alone for B-Cell Non-Hodgkin's Lymphoma
Chemotherapy Versus Combined Modality Treatment in Hodgkin's Disease
Colony-Stimulating Factors for Prevention of Febrile Neutropenia in Children with Acute Lymphoblastic Leukaemia
Compression Stockings for Preventing Deep Vein Thrombosis in Airline Passengers
Computer-Assisted Management of Anticoagulant Therapy
Corticosteroids for Preventing Graft-Versus-Host Disease after Allogeneic Myeloablative Stem Cell Transplantation
Desferrioxamine Mesylate for Iron Overload in Transfusion-Dependent Thalassaemia
Drug-Induced Thrombocytopenia
Drugs for Discoid Lupus Erythematosus
Drugs for Preventing Red Blood Cell Dehydration in People with Sickle Cell Disease
Duration and Intensity of Maintenance Chemotherapy in Acute Lymphoblastic Leukaemia in Children
Duration of Anticoagulant Therapy in Venous Thromboembolism
Early Versus Deferred Treatment for Early Stage Multiple Myeloma
Enteral Iron Supplementation in Preterm and Low Birth Weight Infants
Erythropoietin for Chronic Renal Failure Anaemia
Erythropoietin in Oncological Anaemia
Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for First Episode of Venous Thromboembolism Vs Fatal Bleeding during Continued Anticoagulation
Fondaparinux in the Prevention of Venous Thromboembolism after Surgery
G-CSF for the Prophylaxis of Neutropenic Fever in Patients with Small Cell Lung Cancer
Granulocyte Transfusions for Preventing Infections in Patients with Neutropenia or Neutrophil Dysfunction
Granulopoiesis-Stimulating Factors to Prevent Adverse Effects in the Treatment of Malignant Lymphoma
Haemoglobin and Haematocrit Targets for the Anaemia of Chronic Kidney Disease
Haemoglobin Colour Scale for Anaemia Diagnosis Where There is No Laboratory
High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation (Hdt) as First-Line Therapy in Aggressive Non-Hodgkin's Lymphoma (NHL)
Home Versus in-Patient Treatment for Deep Vein Thrombosis
Hydroxychloroquine in the Treatment of Systemic Lupus Erythematosus
Hydroxyurea for Sickle Cell Disease
Hydroxyurea in the Treatment of High-Risk Essential Thrombocythaemia
Immunoglobulin Prophylaxis in Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Interventions for AIDS-Associated Hodgkin's Lymphoma
Interventions for Haemolytic Uraemic Syndrome (Hus) and Thrombotic Thrombocytopenic Purpura (TTP)
Investigation of Anaemia in a Child
Iron Supplementation for Improving Prevalence of Anaemia and Iron Status in Menstruating Women
Iron Therapy for Improving Psychomotor Development and Cognitive Function in Children Under the Age of Three
Low-Dose Aspirin for Patients with Polycythaemia Vera
Low-Molecular-Weight Heparins (Lmwh) Versus Unfractionated Heparin for Venous Thromboembolism
Maintenance Treatment with Interferon in Multiple Myeloma
Melphalan and Prednisolone Plus Thalidomide Compared to other Treatments for Multiple Myeloma in the Elderly
Oprelvekin in Chemotherapy-Induced Thrombocytopenia
Oral Deferiprone for Iron Chelation in People with Thalassaemia
Oral Vitamin B12 Versus Intramuscular Vitamin B12 for Vitamin B12 Deficiency
Parenteral Versus Oral Iron Therapy for Adults and Children with Chronic Kidney Disease
Perioperative Allogeneic Blood Transfusion in Patients with Cancer
Piracetam for Painful Sickle Cell Disease Crises
Prophylactic Antibiotics for Preventing Pneumococcal Infection in Children with Sickle Cell Disease
Prophylactic Clotting Factor Concentrates to Prevent Bleeding Complications in Hemophilia A or B
Prophylaxis for Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients
Purine Antagonists Compared to Alkylating Agents for Chronic Lymphocytic Leukaemia
Recombinant Factor Viia for Bleeding in Patients Without Haemophilia
Risk of Pulmonary Embolism Associated with Factor V (Fva) Leiden
Rituximab as Maintenance Therapy for Patients with Follicular Lymphoma
Steroid Hormones for Contraception in Women with Sickle Cell Disease
Systemic Therapy for Mycosis Fungoides and Sezary Syndrome
Transfusion Thresholds for Guiding Allogeneic Red Blood Cell Transfusion
Treatment for Anemia in People with AIDS
Treatments for Iron-Deficiency Anaemia in Pregnancy
Vitamin K Antagonists or Low-Molecular Weight Heparin for Venous Thromboembolism
Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Wells Score and D-Dimer in the Diagnosis of Deep Vein Thrombosis